Scholarlink

Purpose <p>This study aimed to investigate the radiosensitizing potential of β-caryophyllene (BCP), a natural CB2 receptor agonist, in colorectal cancer (CRC) cells and to elucidate the underlying molecular mechanisms.</p> Methods <p>Murine CT26 and human HCT116 CRC cells were treated with BCP alone or in combination with radiotherapy (RT). Cell viability was evaluated using the MTT assay, and combination index (CI) values were calculated to assess synergy. Flow cytometry and immunofluorescence were used to analyze cell cycle distribution and DNA damage. Protein expression levels of PPARγ, phosphorylated AKT (pAKT), cyclin D1, Bax, Bcl-2, and cleaved caspase-3 were examined by western blot.</p> Results <p>BCP synergistically enhanced RT-induced cytotoxicity in both CRC cell lines, with CI values ranging from 0.92 to 0.70 in CT26 cells and from 0.78 to 0.68 in HCT116 cells at 4 and 8&#xa0;Gy irradiation. The combination treatment resulted in significant G2/M arrest and sustained γH2AX expression at both 24 and 48&#xa0;h, indicating persistent DNA double-strand breaks. BCP suppressed pAKT and cyclin D1 levels while upregulated PPARγ expression. Activated apoptosis was verified by increased Bax/Bcl-2 ratios and elevated cleaved caspase-3 levels.</p> Conclusion <p>BCP enhances the radiosensitivity of CRC cells by promoting RT-induced DNA damage and triggering PPARγ-mediated apoptotic pathways. These findings support its potential as a natural radiosensitizer in CRC treatment.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

β-Caryophyllene Induces PPARγ-Mediated Apoptosis and Enhances the Radiosensitivity in Colorectal Cancer Cells

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月12日

查看全文
  • Hui-Wen Chan,
  • Deng-Yu Kuo,
  • Yu-Chieh Jill Kao,
  • Yun-Xuan Tang,
  • Hui-Yen Chuang

摘要

Purpose

This study aimed to investigate the radiosensitizing potential of β-caryophyllene (BCP), a natural CB2 receptor agonist, in colorectal cancer (CRC) cells and to elucidate the underlying molecular mechanisms.

Methods

Murine CT26 and human HCT116 CRC cells were treated with BCP alone or in combination with radiotherapy (RT). Cell viability was evaluated using the MTT assay, and combination index (CI) values were calculated to assess synergy. Flow cytometry and immunofluorescence were used to analyze cell cycle distribution and DNA damage. Protein expression levels of PPARγ, phosphorylated AKT (pAKT), cyclin D1, Bax, Bcl-2, and cleaved caspase-3 were examined by western blot.

Results

BCP synergistically enhanced RT-induced cytotoxicity in both CRC cell lines, with CI values ranging from 0.92 to 0.70 in CT26 cells and from 0.78 to 0.68 in HCT116 cells at 4 and 8 Gy irradiation. The combination treatment resulted in significant G2/M arrest and sustained γH2AX expression at both 24 and 48 h, indicating persistent DNA double-strand breaks. BCP suppressed pAKT and cyclin D1 levels while upregulated PPARγ expression. Activated apoptosis was verified by increased Bax/Bcl-2 ratios and elevated cleaved caspase-3 levels.

Conclusion

BCP enhances the radiosensitivity of CRC cells by promoting RT-induced DNA damage and triggering PPARγ-mediated apoptotic pathways. These findings support its potential as a natural radiosensitizer in CRC treatment.

Graphical Abstract